IV selexipag can be used as a bridging therapy

Jun 9, 2025

1 min read

Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily impossible. People might be unable to swallow or have other medical conditions that interfere with their ability to take pills. A small study looked at whether temporarily giving selexipag as an intravenous infusion was safe and effective. They found that it was.

Read the Therapeutics and Clinical Risk Management paper

Recent Posts

More than half of pulmonary fibrosis patients have PH

There is not much data looking at pulmonary hypertension (PH) in interstitial lung disease, except in idiopathic pulmonary fibrosis (IPF). A study of patients with pulmonary fibrosis found that 60.7%

Frequent imaging of children with PH may lead to high radiation doses

A 41-study review of children with non-cancer chronic diseases looked at how much radiation they were exposed to during their relatively frequent medical imaging. Children with PH were included. The r

What affects physical activity for people with PH?

A UK study examined the factors that affected physical activity participation among people with pulmonary hypertension (PH). They found four themes: fear of breathlessness; lack of motivation and a de

Comments